4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (FDMT)

CUSIP: 35104E100

Q4 2021 13F Holders as of 31 Dec 2021

Holder snapshot 6 signals
Share change
+3,985,023
SEC-reported price per share
$21.94
Number of holders
77
Value change
+$81,054,878
Number of buys
62
Number of sells
14
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
51,571,939

Security key

35104E100

Report period

Q4 2021

Institutions

77

Top holders

10

Ownership snapshot

Top reported holders of FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VIKING GLOBAL INVESTORS LP
Disclosed value leader
VIKING GLOBAL INVESTORS LP
Comparable rows
15/15
Latest evidence
30 Sep 2021
13F Lead comparable stake: 7.6% Showing 1-6 of 15 holder rows.

Quick read

VIKING GLOBAL INVESTORS LP leads the comparable SEC ownership view at 7.6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VIKING GLOBAL INVESTORS LP's linked filing trail.
Comparable ownership Top 5
VIKING GLOBAL INVESTORS LP 7.6%
BVF INC/IL 3.9%
JANUS HENDERSON GROUP PLC 2.9%
BlackRock Finance, Inc. 2.8%
Casdin Capital, LLC 2.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VIKING GLOBAL INVESTORS LP
13F
Company
13F
7.6%
$106,206,000
3,937,914 shares
30 Sep 2021
BVF INC/IL
13F
Company
13F
3.9%
$54,098,000
2,005,862 shares
30 Sep 2021
JANUS HENDERSON GROUP PLC
13F
Company
13F
2.9%
$41,032,000
1,521,103 shares
30 Sep 2021
BlackRock Finance, Inc.
13F
Company
13F
2.8%
$38,794,000
1,438,363 shares
30 Sep 2021
Casdin Capital, LLC
13F
Company
13F
2.2%
$30,084,000
1,115,455 shares
30 Sep 2021
Aquilo Capital Management, LLC
13F
Company
13F
2.1%
$29,665,000
1,099,944 shares
30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
77
Shares
24,702,968
Rows available
77
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
61
Q4 2021 holders
77
Holder diff
16
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 value Q4 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .